Fieldview Capital Management LLC Cuts Stake in Cigna Group $CI

Fieldview Capital Management LLC lowered its stake in shares of Cigna Group (NYSE:CI) by 41.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,598 shares of the health services provider’s stock after selling 2,496 shares during the period. Fieldview Capital Management LLC’s holdings in Cigna Group were worth $990,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the 4th quarter valued at about $28,000. Lodestone Wealth Management LLC purchased a new stake in Cigna Group during the 4th quarter valued at about $32,000. Creative Financial Designs Inc. ADV grew its stake in shares of Cigna Group by 147.3% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after buying an additional 81 shares during the period. Finally, Activest Wealth Management grew its stake in shares of Cigna Group by 1,050.0% in the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after buying an additional 126 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several analyst reports. UBS Group increased their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Wells Fargo & Company increased their price target on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. The Goldman Sachs Group increased their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Finally, Truist Financial increased their price target on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Stock Performance

Shares of CI stock opened at $297.77 on Monday. The firm’s 50 day moving average price is $282.53 and its 200-day moving average price is $278.05. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The firm has a market cap of $78.77 billion, a P/E ratio of 12.62, a P/E/G ratio of 1.15 and a beta of 0.28.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the business posted $6.74 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.